Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 412

Similar articles for PubMed (Select 9194107)

2.

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

Church DA, Kanga JF, Kuhn RJ, Rubio TT, Spohn WA, Stevens JC, Painter BG, Thurberg BE, Haverstock DC, Perroncel RY, Echols RM.

Pediatr Infect Dis J. 1997 Jan;16(1):97-105; discussion 123-6.

PMID:
9002118
4.

Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.

Schaad UB, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B.

Pediatr Infect Dis J. 1997 Jan;16(1):106-11; discussion 123-6.

PMID:
9002119
5.

Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.

Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, Jarvinen A, Kennedy D, Colebatch KA, Hansman D, Parsons DW.

Pediatr Pulmonol. 2001 May;31(5):367-76.

PMID:
11340683
6.

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E; Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.

Clin Microbiol Infect. 2005 Sep;11(9):690-703. Review.

7.
8.

Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.

Vic P, Ategbo S, Turck D, Husson MO, Launay V, Loeuille GA, Sardet A, Deschildre A, Druon D, Arrouet-Lagande C.

Arch Dis Child. 1998 Jun;78(6):536-9.

9.

Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.

Gold R, Overmeyer A, Knie B, Fleming PC, Levison H.

Pediatr Infect Dis. 1985 Mar-Apr;4(2):172-7.

PMID:
3885181
10.

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.

Smyth A, Tan KH, Hyman-Taylor P, Mulheran M, Lewis S, Stableforth D, Prof Knox A; TOPIC Study Group.

Lancet. 2005 Feb 12-18;365(9459):573-8.

PMID:
15708100
11.

Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

Lenoir G, Antypkin YG, Miano A, Moretti P, Zanda M, Varoli G, Monici Preti PA, Aryayev NL.

Paediatr Drugs. 2007;9 Suppl 1:11-20.

PMID:
17536871
12.

Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Schaad UB, Wedgwood-Krucko J, Guenin K, Buehlmann U, Kraemer R.

Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):858-65.

PMID:
2512129
13.

Ciprofloxacin therapy in cystic fibrosis.

Scully BE, Nakatomi M, Ores C, Davidson S, Neu HC.

Am J Med. 1987 Apr 27;82(4A):196-201.

PMID:
3555036
14.
15.

A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.

Chuchalin A, Csiszér E, Gyurkovics K, Bartnicka MT, Sands D, Kapranov N, Varoli G, Monici Preti PA, Mazurek H.

Paediatr Drugs. 2007;9 Suppl 1:21-31.

PMID:
17536872
16.

Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Stenvang Pedersen S, Pressler T, Pedersen M, Høiby N, Friis-Møller A, Koch C.

Scand J Infect Dis. 1986;18(2):133-7.

PMID:
3518048
17.

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.

Treggiari MM, Rosenfeld M, Mayer-Hamblett N, Retsch-Bogart G, Gibson RL, Williams J, Emerson J, Kronmal RA, Ramsey BW; EPIC Study Group.

Contemp Clin Trials. 2009 May;30(3):256-68. doi: 10.1016/j.cct.2009.01.003. Epub 2009 Jan 15.

19.

Use of ciprofloxacin in cystic fibrosis patients.

Bosso JA.

Am J Med. 1989 Nov 30;87(5A):123S-127S.

PMID:
2589355
20.

Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections.

Gaut PL, Carron WC, Ching WT, Meyer RD.

Am J Med. 1989 Nov 30;87(5A):169S-175S.

PMID:
2686417
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk